HK1049121B - 用於心臟病的抗人線粒體腺苷酸激酶同工酶抗體，診斷製劑和診斷試劑盒 - Google Patents

用於心臟病的抗人線粒體腺苷酸激酶同工酶抗體，診斷製劑和診斷試劑盒

Info

Publication number
HK1049121B
HK1049121B HK03101368.9A HK03101368A HK1049121B HK 1049121 B HK1049121 B HK 1049121B HK 03101368 A HK03101368 A HK 03101368A HK 1049121 B HK1049121 B HK 1049121B
Authority
HK
Hong Kong
Prior art keywords
cardiac disease
diagnostic
adenylate kinase
formulation
human mitochondrial
Prior art date
Application number
HK03101368.9A
Other languages
English (en)
Other versions
HK1049121A1 (en
Inventor
金曉駿
曹基勝
李相旻
Original Assignee
金曉駿
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 金曉駿 filed Critical 金曉駿
Publication of HK1049121A1 publication Critical patent/HK1049121A1/xx
Publication of HK1049121B publication Critical patent/HK1049121B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1229—Phosphotransferases with a phosphate group as acceptor (2.7.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
HK03101368.9A 2000-02-08 2003-02-22 用於心臟病的抗人線粒體腺苷酸激酶同工酶抗體，診斷製劑和診斷試劑盒 HK1049121B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0005808A KR100414637B1 (ko) 2000-02-08 2000-02-08 사람 미토콘드리아 아데닐레이트 키나제 이소자임들에대한 항체와 면역학적 제제 및 심장질환 진단키트
PCT/KR2000/000882 WO2001058482A1 (en) 2000-02-08 2000-08-10 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease

Publications (2)

Publication Number Publication Date
HK1049121A1 HK1049121A1 (en) 2003-05-02
HK1049121B true HK1049121B (zh) 2011-01-14

Family

ID=19644714

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101368.9A HK1049121B (zh) 2000-02-08 2003-02-22 用於心臟病的抗人線粒體腺苷酸激酶同工酶抗體，診斷製劑和診斷試劑盒

Country Status (14)

Country Link
US (1) US7514227B2 (zh)
EP (1) EP1165133B1 (zh)
JP (1) JP3736798B2 (zh)
KR (1) KR100414637B1 (zh)
CN (1) CN1368888B (zh)
AT (1) ATE493658T1 (zh)
AU (1) AU784153B2 (zh)
BR (1) BR0010712A (zh)
CA (1) CA2366468C (zh)
DE (1) DE60045444D1 (zh)
ES (1) ES2355128T3 (zh)
HK (1) HK1049121B (zh)
RU (1) RU2262939C2 (zh)
WO (1) WO2001058482A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003264980A1 (en) * 2002-09-28 2004-04-19 Hyo-Joon Kim Monoclonal antibody specific for human mitochondrial adenylate kinase isozyme 3
SG169395A1 (en) 2006-02-09 2011-03-30 Univ South Florida Detection of cancer by elevated levels of bcl-2
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
CN104237505B (zh) * 2014-09-17 2016-05-04 杭州特马赛生物技术有限公司 一种检测阿司匹林和氯吡咯雷药物双重抵抗的试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417593D0 (en) * 1994-09-01 1994-10-19 Secr Defence Luciferase labelling method
US5856160A (en) * 1997-03-31 1999-01-05 Incyte Pharmaceuticals, Inc. Mitochondrial adenylate kinase
US6558903B1 (en) * 1999-06-30 2003-05-06 Millennium Pharmaceuticals, Inc. Kinases and uses thereof
JP2003531580A (ja) * 2000-02-25 2003-10-28 メトリオジェーン・バイオサイエンシイズ・インコーポレイテッド 子宮内膜症関連マーカー及びその使用

Also Published As

Publication number Publication date
EP1165133B1 (en) 2010-12-29
CN1368888B (zh) 2010-11-03
JP2003522158A (ja) 2003-07-22
CA2366468A1 (en) 2001-08-16
US7514227B2 (en) 2009-04-07
AU784153B2 (en) 2006-02-09
ATE493658T1 (de) 2011-01-15
AU6734800A (en) 2001-08-20
ES2355128T3 (es) 2011-03-23
HK1049121A1 (en) 2003-05-02
JP3736798B2 (ja) 2006-01-18
RU2262939C2 (ru) 2005-10-27
EP1165133A4 (en) 2005-06-29
WO2001058482A1 (en) 2001-08-16
CN1368888A (zh) 2002-09-11
US20070122846A1 (en) 2007-05-31
KR100414637B1 (ko) 2004-01-13
KR20010077769A (ko) 2001-08-20
EP1165133A1 (en) 2002-01-02
CA2366468C (en) 2010-02-02
BR0010712A (pt) 2002-02-05
DE60045444D1 (de) 2011-02-10

Similar Documents

Publication Publication Date Title
Nilsson et al. Ground reaction forces at different speeds of human walking and running
El-Najjar et al. The paleoepidemiology of porotic hyperostosis in the American Southwest: radiological and ecological considerations
Cordain et al. Evolutionary Aspectsof Exercise
PL365936A1 (en) Nutritional composition
CA2329776A1 (en) Antibody against lar phosphatase subunit
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
BRPI0411803A (pt) anticorpos dirigidos aos mutantes de deleção de receptor de fator de crescimento epidérmico e seus usos
GT200800132A (es) Anticuerpos anti-il-23 humanos, composiciones, metodos y usos
UA95238C2 (uk) Імуногенна композиція
WO2003057837A3 (en) Methods for using anti-muc18 antibodies
Barber Secular changes in standards of bodily attractiveness in American women: Different masculine and feminine ideals
CY1112139T1 (el) Μια φαρμακευτικη συνθεση περιλαμβανουσα κρυσταλλικη ριτοναβιρη μορφη ιι και ενα παρασκευασμα εξ αυτης
MXPA05006269A (es) Uso de un extracto de granos de cafe descafeinado en la preparacion de una composicion destinada a estimular la funcion sebacea de la piel mediante administracion oral.
IL180612A0 (en) Materials and methods for immune system stimulation
WO2004110369A3 (en) Cell surface protein associated with human chronic lymphocytic leukemia
HK1049121A1 (en) Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease
Joo Study on development of tea by utilizing Lycium chinense and Cornus officinalis
Montoya et al. Olympic year impact on leisure-time physical activity rates within and across Canadian provinces and territories
Edgecombe Homology of cephalic sutures in Chilopoda: the antennocellar sutures of Scutigeromorpha
Fehrsen Malnutrition in South Africa-some thoughts on the problem
CN201294905Y (zh) 弹力鞋
Hlavač et al. Endogejski i špiljski Coleoptera Balkana. IX. Bilješke o rodu Tychobythinus (Coleoptera: Staphylinidae: Pselaphinae) s jadranske obale s opisom nove vrste
Lokaryeva FEATURES OF PROFESSIONAL FORMATION OF FUTURE TEACHERS OF ART SUBJECTS AESTHETIC CYCLE
Spears Winning external research funding
Baker A study of the behavioural profiles of elite slalom canoeists

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140810